Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 8098078)

1.

First trimester topical tretinoin and congenital disorders.

Jick SS, Terris BZ, Jick H.

Lancet. 1993 May 8;341(8854):1181-2.

PMID:
8098078
2.

Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.

Williams PL, Crain MJ, Yildirim C, Hazra R, Van Dyke RB, Rich K, Read JS, Stuard E, Rathore M, Mendez HA, Watts DH; Pediatric HIV/AIDS Cohort Study.

JAMA Pediatr. 2015 Jan;169(1):48-55. doi: 10.1001/jamapediatrics.2014.1889.

PMID:
25383770
3.

Trimethoprim use before pregnancy and risk of congenital malformation: reanalyzed using a case-crossover design and a case-time-control design.

Sun Y, Wu CS, Olsen J.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1076-83. doi: 10.1002/pds.3691. Epub 2014 Aug 11.

PMID:
25111783
4.

First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.

Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M.

Hum Reprod Update. 2014 Sep-Oct;20(5):656-69. doi: 10.1093/humupd/dmu022. Epub 2014 May 25. Review.

PMID:
24861556
5.

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

Ford N, Mofenson L, Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, Shaffer N, Renaud F.

AIDS. 2014 Mar;28 Suppl 2:S123-31. doi: 10.1097/QAD.0000000000000231. Review.

PMID:
24849471
6.

Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.

Ephross SA, Sinclair SM.

Headache. 2014 Jul-Aug;54(7):1158-72. doi: 10.1111/head.12375. Epub 2014 May 7.

PMID:
24805878
7.

Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.

Diav-Citrin O, Shechtman S, Tahover E, Finkel-Pekarsky V, Arnon J, Kennedy D, Erebara A, Einarson A, Ornoy A.

Am J Psychiatry. 2014 Jul;171(7):785-94. doi: 10.1176/appi.ajp.2014.12111402.

PMID:
24781368
8.

Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.

Andersen SL, Olsen J, Wu CS, Laurberg P.

J Clin Endocrinol Metab. 2013 Nov;98(11):4373-81. doi: 10.1210/jc.2013-2831. Epub 2013 Oct 22.

PMID:
24151287
9.

Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.

Pasternak B, Svanström H, Mølgaard-Nielsen D, Melbye M, Hviid A.

JAMA. 2013 Oct 16;310(15):1601-11. doi: 10.1001/jama.2013.278343.

PMID:
24129464
10.

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.

Ban L, Tata LJ, Fiaschi L, Card T.

Gastroenterology. 2014 Jan;146(1):76-84. doi: 10.1053/j.gastro.2013.09.061. Epub 2013 Oct 12.

PMID:
24126096
11.

Antidepressant use during early pregnancy and the risk of congenital anomalies.

Vasilakis-Scaramozza C, Aschengrau A, Cabral H, Jick SS.

Pharmacotherapy. 2013 Jul;33(7):693-700. doi: 10.1002/phar.1211. Epub 2013 Jun 6.

PMID:
23744675
12.

Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.

Floridia M, Mastroiacovo P, Tamburrini E, Tibaldi C, Todros T, Crepaldi A, Sansone M, Fiscon M, Liuzzi G, Guerra B, Vimercati A, Vichi F, Vicini I, Pinnetti C, Marconi AM, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

BJOG. 2013 Nov;120(12):1466-75. doi: 10.1111/1471-0528.12285. Epub 2013 May 31.

PMID:
23721372
13.

Antihypertensive drugs and the risk of congenital anomalies.

Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS.

Pharmacotherapy. 2013 May;33(5):476-82. doi: 10.1002/phar.1212. Epub 2013 Apr 1.

PMID:
23553869
14.

Asthma drugs and the risk of congenital anomalies.

Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS.

Pharmacotherapy. 2013 Apr;33(4):363-8. doi: 10.1002/phar.1213. Epub 2013 Feb 28.

PMID:
23450814
15.

Birth defects after exposure to misoprostol in the first trimester of pregnancy: prospective follow-up study.

Vauzelle C, Beghin D, Cournot MP, Elefant E.

Reprod Toxicol. 2013 Apr;36:98-103. doi: 10.1016/j.reprotox.2012.11.009. Epub 2012 Dec 1.

PMID:
23207166
16.

Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring.

Bay Bjørn AM, Ehrenstein V, Hundborg HH, Nohr EA, Sørensen HT, Nørgaard M.

Am J Ther. 2014 Mar-Apr;21(2):73-80. doi: 10.1097/MJT.0b013e3182491e02.

PMID:
23011170
17.

Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.

Daniel S, Matok I, Gorodischer R, Koren G, Uziel E, Wiznitzer A, Levy A.

J Rheumatol. 2012 Nov;39(11):2163-9. doi: 10.3899/jrheum.120453. Epub 2012 Sep 15.

PMID:
22984274
18.

Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations.

Brender JD, Werler MM, Shinde MU, Vuong AM, Kelley KE, Huber JC Jr, Sharkey JR, Griesenbeck JS, Romitti PA, Malik S, Suarez L, Langlois PH, Canfield MA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2012 Sep;94(9):701-13. doi: 10.1002/bdra.23060. Epub 2012 Aug 18.

19.

The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.

Bar-Oz B, Weber-Schoendorfer C, Berlin M, Clementi M, Di Gianantonio E, de Vries L, De Santis M, Merlob P, Stahl B, Eleftheriou G, Maňáková E, Hubičková-Heringová L, Youngster I, Berkovitch M.

Drug Saf. 2012 Jul 1;35(7):589-98. doi: 10.2165/11630920-000000000-00000.

PMID:
22702640
20.

Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.

Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K, Ito K.

J Clin Endocrinol Metab. 2012 Jul;97(7):2396-403. doi: 10.1210/jc.2011-2860. Epub 2012 Apr 30.

PMID:
22547422
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk